The breast cancer program is working to improve early detection of potentially lethal breast cancer by identifying biomarkers that complement existing imaging methods and by developing new imaging alternatives.

Breast cancer is the most common type of cancer among American women, except for skin cancers. About 1 in 8 (12%) women in the U.S. will develop invasive breast cancer during their lifetime, according to the American Cancer Society. But with treatment and early detection techniques, millions of women are surviving breast cancer today.

Mammography is currently the best available tool for breast cancer detection and has been shown to reduce mortality in clinical trials. However, the method misses some tumors, particularly in women with dense breast tissue. Mammography also suffers from a high rate of false positives, in which an imaging finding turns out not to be cancer after follow-up tests.

Learn more about the Canary Breast Cancer Program

Dr. Pitteri works in breast and prostate cancer, and is involved in examining proteins in the blood, as well as differences in glycosylation on those proteins, to incorporate them into an early detection blood test.